News | Radiation Therapy | September 22, 2017

Penn Medicine Treats World's First Patient on Varian's Halcyon System

Head & neck cancer patient treated in just 13 minutes with advanced platform

Penn Medicine Treats World's First Patient on Varian's Halcyon System

September 22, 2017 — Varian Medical Systems announced a patient at Penn Medicine, with head & neck cancer, became the first person in the world to be treated on Varian's new Halcyon radiation therapy platform. Halcyon is well suited to handle the majority of cancer patients, according to the company, offering advanced treatments for prostate, breast, head & neck, and many other forms of cancer.

The treatment for this patient at Penn Medicine was a complex case that involved the delivery of nine fields. The total patient time in the treatment room, including set-up, imaging, three minutes of beam time and patient discharge, was only 13 minutes. Typically, a treatment like this using other radiation technology can take 10 minutes of beam time and 20 minutes total treatment time.

Halcyon is an advanced system that is more comfortable for the patient while delivering ease of use for healthcare providers, accelerated installation timeframes, expedited commissioning, simplified training and automated treatment.

"We are proud to have delivered the world's first Halcyon treatment, which contributes to our ongoing mission to provide patients the widest and most advanced array of cancer treatment options," said James Metz, M.D., chair of radiation oncology at Penn Medicine. "This platform combines reduced treatment time with simplified operation, and for some diseases, it even lets us be more precise with the radiation we're delivering."

For more information: www.varian.com

Related Content

Mitchell Cancer Institute Selects RayStation for TomoTherapy Planning
News | Treatment Planning | February 16, 2018
The University of South Alabama Mitchell Cancer Institute (MCI) in Mobile, Ala., has selected RayStation as its...
Radiography Education Enrollment Shows Marginal Rise in 2017
News | Business | February 15, 2018
Directors of radiography educational programs report the number of enrolled students increased slightly in 2017, while...
Varian Acquires Mobius Medical Systems
News | Quality Assurance (QA) | February 06, 2018
February 6, 2018 – Varian announced it has acquired privately-held Mobius Medical Systems, a...
Microbubbles Make Breast Cancer More Susceptible to Radiation Therapy
News | Women's Health | February 01, 2018
February 1, 2018 – Injecting breast cancer with oxygen-filled microbubbles makes tumors three-times more sensitive to
​ITN Celebrates World Cancer Day 2018
News | Radiation Oncology | February 01, 2018
World Cancer Day takes place annually on Feb.
RayStation Selected for India’s First Proton Center
News | Proton Therapy | February 01, 2018
February 1, 2018 – Apollo Hospitals, Asia´s foremost integrated healthcare provider, has selected RayStation for a ne
Varian Signs Agreement to Acquire Sirtex
News | Radiation Therapy | January 31, 2018
January 31, 2018 — Varian Medical Systems announced it has signed an agreement to acquire all the outstanding shares

This PET/CT shows metastasis of tumors, taken with the Philips TruFlight Select.

Feature | Radiation Oncology | January 31, 2018 | By Emily Clemons
Technological and scientific advances in radiation oncology are allowing practitioners to put patients first in...
RayStation Selected for London's Charing Cross Hospital and Hammersmith Hospital
News | Treatment Planning | January 30, 2018
Imperial College Healthcare NHS Trust in London, U.K., has chosen RayStation as the sole treatment planning system for...
Overlay Init